Renovis, Inc.
Renovis reports first quarter 2006 revenues of $2.5 million
Published in Mental Health Business Week, May 27th, 2006
This compares to first quarter 2005 revenue of $0.7 million from the company's collaboration with Genentech, Inc. in the areas of neurological disorders and antiangiogenesis.
Research and development expenses for the quarter ended March 31, 2006 were $6.9 million, compared to $8.4 million during the same period in 2005. The decrease in research and development expenses primarily reflects lower clinical development...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Mental Health Business Week
More Articles from Mental Health Business Week
- Avigen, Inc.
Avigen reports loss of $0.38 per share - Maas Biolab, LLC
Maas Biolab receives $50,000 grant to develop cyclosporin neuroprotection products - Medtronic, Inc.
Medtronic announces clinical trials strategy for neurological and urological therapies - Psychiatric Solutions, Inc.
Psychiatric Solutions reports first quarter revenues increased 80% - Accuray Incorporated
Spinal tumor treatments with robotic radiosurgical system up 75% since April 2005 launch - American Medical Association
Maternal difficulties may increase risk of behavior problems in children - More from this issue of Mental Health Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
